Preliminary results from a cohort study show no statistically significant difference in hospitalisation, 28-day case fatality and reinfection between the new variant and wild-type comparator cases. Preliminary results from a cohort study show no statistically significant difference in hospitalisation and 28-day case fatality between cases with the new variant (VOC 201212/01) and wild-type comparator cases. […]

New variant does not increase reinfection risk, disease severity, deaths — Science Chronicle